All-trans-retinoic acid in acute promyelocytic leukemia
Academic Article
Overview
MeSH Major
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Leukemia, Promyelocytic, Acute
Tretinoin
abstract
All-trans-retinoic acid as induction or maintenance treatment improves disease-free and overall survival as compared with chemotherapy alone and should be included in the treatment of acute promyelocytic leukemia.
